Understanding how immune cells respond to HIV vaccines

Revealing the Biophysics of the Germinal Center Microenvironment

NIH-funded research University of Texas Med Br Galveston · NIH-10983781

This study is looking at how our immune system's B cells work together to fight HIV, using mice with human genes to see which B cells can make the best antibodies, with the hope of helping to create a better HIV vaccine for everyone.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Texas Med Br Galveston NIH-funded
Lab location1 site (Galveston, United States)
Project IDNIH-10983781 on NIH RePORTER

What this research studies

This research investigates the dynamics of immune responses to HIV vaccines, focusing on the competition among B cells within germinal centers. By using a model system with mice that have human genes for a specific antibody, the study aims to uncover how certain B cells can successfully compete to produce protective antibodies against HIV. The research seeks to identify factors like antigen affinity and precursor frequency that influence the effectiveness of these immune responses. Ultimately, the goal is to enhance our understanding of B cell biology to aid in the development of an effective HIV vaccine.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals at high risk for HIV who are interested in vaccine development and immune response studies.

Not a fit: Patients who are already HIV positive or those who do not have a vested interest in HIV vaccine research may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of a more effective HIV vaccine, improving prevention strategies for individuals at risk of HIV infection.

How similar studies have performed: Previous research has shown promise in understanding B cell responses to vaccines, but this specific approach focusing on HIV vaccine development is relatively novel.

Where this research is happening

Galveston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acquired Immune Deficiency Syndrome VirusAcquired Immunodeficiency Syndrome Virus
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.